Physician- and Practice-Level Variation in Clinical Trial Participation Among Patients With Advanced Cancer - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Variability in Clinical Trial Enrollment for Patients with Advanced Cancer at the Physician and Practice Levels

  • By

  • Changchuan Jiang

  • Chuan Angel Lu

  • Joshua M. Liao

  • Ryan D. Nipp

  • K. Robin Yabroff

  • Helen H. Moon

  • Song Zhang

  • Xin Hu

  • Tian Zhang

  • October 6, 2026

Share

Clinical Scorecard: Variability in Clinical Trial Enrollment for Patients with Advanced Cancer at the Physician and Practice Levels

At a Glance

CategoryDetail
ConditionAdvanced Cancer
Key MechanismsClinical trial participation is influenced by physician referral practices and practice infrastructure.
Target PopulationAdults aged 18 years or older with advanced or metastatic solid malignancies.
Care SettingOncology practices with varying trial availability and infrastructure.

Key Highlights

  • Enrollment in clinical trials for advanced cancer remains below 10%.
  • Physicians and practices are essential gatekeepers for trial participation.
  • Variation in trial engagement exists due to differing organizational priorities.
  • A national cohort study analyzed over 200,000 patients with advanced cancer.
  • Data derived from the US Flatiron Health Research Database.

Guideline-Based Recommendations

Diagnosis

  • Patients must have a diagnosis of advanced or metastatic solid malignancies.

Management

  • Physicians should initiate discussions about clinical trial participation.

Monitoring & Follow-up

  • Track clinical trial participation rates and associated delivery system factors.

Risks

  • Potential disparities in trial access based on race and ethnicity.

Patient & Prescribing Data

Adults with advanced or metastatic cancer treated from January 1, 2011, through December 31, 2024.

Clinical trial participation operationalized as receipt of a clinical study drug.

Clinical Best Practices

  • Ensure adequate infrastructure for clinical trial options in oncology practices.
  • Identify and support 'super enrollers' to enhance trial participation.
  • Address systemic barriers to improve equitable access to clinical trials.

Related Resources & Content

Original Source(s)

Related Content